Petersen
(1983) DMCM: a potent convusive benzodiazepine receptor ligand.
Eur.J.Pharmacol. 94 117. Sieveet al (2001) Pain and
negative affect: evidence the inverse benzodiazepine agonist DMCM inhibits pain
and learning in rats. Psychopharmacol. 153 180. Contoet
al (2005) Behavioral differences between subgroups of rats with high and
low threshold to clonic convulsions induced by DMCM, a benzodiazepine inverse
agonist. Pharmacol.Biochem.Behav. 82 417.
Selective antagonist of neuro-steroid potentiation and direct gating of GABAA receptors. Selectively reduces the effects of 5α-reduced steroids compared to 5β-reduced steroids & displays no effect on potentiation evoked by barbiturates & benzodiazepines. Attenuates 3α,5α-THP-induced loss of righting reflex and total sleep time following i.c.v administration in rats.